Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA New Drug Approval Count May Fall Back To Earth In 2016

Jul 18 2016

• By Bridget Silverman

2016 earth

Related Content

NME Half-Year Report: CDER Sets Strong Foundation With 14 Novel Approvals

Jul 06 2015

User Fee Extensions Are Key To CDER's First Cycle Review Success

Jan 18 2016

Novel Agents In Line For FDA Action In 2016

Jul 18 2016

CDER’s 14 Approvals In The First Half Of 2016

Jul 18 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Portola Pharmaceuticals, Inc.

Eli Lilly and Company

Roche Holding AG

Genentech, Inc.

AbbVie Inc.

Spectrum Pharmaceuticals, Inc.

Advanced Accelerator Applications SA

Merck & Co., Inc.

Novartis AG

Genmab A/S

Telesta Therapeutics Inc.

Clovis Oncology, Inc.

BioMarin Pharmaceutical Inc.

Teva Pharmaceutical Industries Ltd.

Newron Pharmaceuticals S.p.A.

AstraZeneca PLC

Additional Topics

United States Regulation Approvals BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window